Bystander tumoricidal effect and gap junctional communication in lung cancer cell lines

American Journal of Respiratory Cell and Molecular Biology

Volumn 18, Issue 2, 1998, Pages 205-212

  Imaizumi, Kazuyoshi ^a   Hasegawa, Yoshinori ^a   Kawabe, Tsutomu ^a   Emi, Nobuhiko ^a   Saito, Hidehiko ^a   Naruse, Keiji ^a   Shimokata, Kaoru ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; GANCICLOVIR; OCTANOL; RETINOIC ACID; THYMIDINE KINASE;

ANIMAL; ARTICLE; CARCINOMA; CELL COMMUNICATION; CELL CULTURE; CELL DIVISION; CELL JUNCTION; COCULTURE; DRUG EFFECT; ENZYMOLOGY; GENE VECTOR; GENETICS; HERPES SIMPLEX VIRUS; HUMAN; LUNG TUMOR; METABOLISM; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; PATHOLOGY; PHYSIOLOGY; VIRUS CELL TRANSFORMATION;

1-OCTANOL; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA; CELL COMMUNICATION; CELL DIVISION; CELL TRANSFORMATION, VIRAL; COCULTURE TECHNIQUES; GANCICLOVIR; GAP JUNCTIONS; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MICE; MOLONEY MURINE LEUKEMIA VIRUS; SIMPLEXVIRUS; THYMIDINE KINASE; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031991630     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.18.2.2821     Document Type: Article

References (25)

1. Lee, C. T., H. L. Chen, and D. P. Carbone. 1995. Gene therapy for lung cancer. Ann. Oncol. 6:S61-S63.
2. Culver, K. W., and R. M. Blaese. 1994. Gene therapy for cancer. Trends Genet. 10:174-178.
3. Herrmann, F. 1995. Cancer gene therapy: principles, problems, and perspectives. J. Mol. Med. 73:157-163.
4. Culver, K. W., T. M. Vickers, J. L. Lamsam, H. W. Walling, and T. Seregina. 1995. Gene therapy for solid tumors. Br. Med. Bull. 51:192-204.
5. Curiel, D. T., J. M. Pilewski, and S. M. Albelda. 1996. Gene therapy approaches for inherited and acquired lung diseases. Am. J. Respir. Cell Mol. Biol. 14:1-18.
6. Hasegawa, Y., N. Emi, and K. Shimokata. 1995. Retroviral transfer of HSV1-TK gene into human lung cancer cell line. J. Mol. Med. 73:107-112.
7. Moolten, F. L. 1986. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res. 46:5276-5281.
8. Culver, K. W., Z. Ram, S. Wallbridge, H. Ishii, E. H. Oldfield, and R. M. Blaese. 1992. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550-1552.
9. Freeman, S. M., C. N. Abboud, K. A. Whartenby, C. H. Packman, D. S. Koeplin, F. L. Moolten, and G. N. Abraham. 1993. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53:5274-5283.
10. Pitts, J. D. 1994. Cancer gene therapy: a bystander effect using the gapjunctional pathway. Mol. Carcinogen. 11:127-130.
11. Goldberg, G. S., and J. S. Bertram. 1994. Retinoids, gapjunctional communication and suppression of epithelial tumors. In Vivo 8:745-754.
12. Kumar, N. M., and N. B. Gilula. 1996. The gap junction communication channel. Cell 84:381-388.
13. Yamasaki, T., K. Enomoto, K. Moritake, and T. Maeno. 1994. Analysis of intra- and intercellular calcium signaling in a mouse malignant glioma cell line. J. Neurosurg. 81:420-426.
14. Kuriyama, S., T. Nakatani, K. Masui, T. Sakamoto, K. Tominaga, M. Yoshikawa, H. Fukui, K. Ikenaka, and T. Tsujii. 1995. Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Hepatology 22:1838-1846.
15. Bi, W. L., L. M. Parysek, R. Warnick, and P. J. Stambrook. 1993. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther. 4:725-731.
16. Hasegawa, Y., N. Emi, K. Shimokata, A. Abe, T. Kawabe, T. Hasegawa, T. Kirioka, and H. Saito. 1993. Gene transfer of herpes simplex virus type I thymidine kinase gene as a drug sensitivity gene into human lung cancer cell lines using retroviral vectors. Am. J. Respir. Cell Mol. Biol. 8:655-661.
17. Johnston, M. F., S. A. Simon, and F. Ramon. 1980. Interaction of anaesthetics with electrical synapses. Nature 286:498-499.
18. Reynhout, J. K., P. D. Lampe, and R. G. Johnson. 1992. An activator of protein kinase C inhibits gap junction communication between cultured bovine lens cells. Exp. Cell. Res. 198:337-342.
19. Hossain, M. Z., L. R. Wilkens, P. P. Mehta, W. Loewenstein, and J. S. Bertram. 1989. Enhancement of gapjunctional communication by retinoids correlates with their ability to inhibit neoplastic transformation. Carcinogenesis 10:1743-1748.
20. Tomasetto, C., M. J. Neveu, J. Daley, P. K. Horan, and R. Sager. 1993. Specificity of gap junction communication among human mammary cells and connexin transfectants in culture. J. Cell Biol. 122:157-167.
21. Enomoto, K., K. Furuya, S. Yamagishi, and T. Maeno. 1992. Mechanically induced electrical and intraecllular calcium responses in normal and cancerous mammary cells. Cell Calcium 13:501-511.
22. Wu, J. K., W. G. Cano, S. A. G. Meylaerts, P. Qi, F. Vrionis, and V. Cherington. 1994. Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery 35:1094-1103.
23. Mesnil, M., C. Piccoli, G. Tiraby, K. Willecke, and H. Yamasaki. 1996. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc. Natl. Acad. Sci. USA 93:1831-1835.
24. Fick, J., F. G. Barker II, P. Dazin, E. M. Westphale, E. C. Beyer, and M. A. Israel. 1945. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc. Natl. Acad. Sci. USA 92:11071-11075.
25. Guo, H., P. Acevedo, F. D. Parsa, and J. S. Bertram. 1992. Gap-junctional protein connexin 43 is expressed in dermis and epidermis of human skin: differential modulation by retinoids. J. Invest. Dermatol. 99:460-467.